CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: We next examined propofol’s effect on the survival, proliferation and differentiation of CD34 progenitor cells derived from blast phase CML patients as well as normal bone marrow (NBM) CD34 cells.